Skip to content

Diagnostics

Advanced Cardiometabolic Testing

Advanced cardiometabolic testing measures risk signals that a standard cholesterol panel can miss, including ApoB, lipoprotein(a), inflammation and insulin dynamics, and turns them into a physician-guided prevention plan. It is for adults with a family history, borderline results, or anyone building a serious prevention plan; symptoms are not required, and current chest pain calls for an urgent cardiology evaluation, not an advanced panel. Available in clinic in Coconut Grove, Miami, and by telehealth across Florida.

In-clinic in Coconut Grove and via telehealth across Florida · (305) 930-8891

Medically reviewed by Dr. Elizabeth Isalguez Last reviewed

Key takeaways

  • Standard cholesterol panels can miss meaningful risk: two people with identical LDL-C can carry very different particle burdens.
  • ApoB and lipoprotein(a) describe atherogenic particle number and inherited risk more directly than LDL-C alone.
  • Insulin dynamics often shift years before fasting glucose or HbA1c move, which is where prevention has the most room to work.
  • Lipoprotein(a) is largely genetic and is measured once in a lifetime for most people.
  • Testing is paired with a plan: targets, interventions, and a retest date.

What it supports

Earlier risk detection

Finds patterns years before conventional thresholds flag them.

Actionable targets

Specific markers to improve, with a tracked plan.

Prevention-first

Lifestyle and medical strategies before problems escalate.

What advanced cardiometabolic testing measures

A routine lipid panel reports how much cholesterol is being carried. It does not report how many particles are carrying it, how inflamed the arterial wall is, or how hard your pancreas is working to keep glucose normal. Two people with identical LDL-C can therefore sit at very different risk.

Advanced testing addresses that gap. Depending on your history it may include ApoB, lipoprotein(a), LDL and HDL particle number and size, remnant cholesterol, hs-CRP, fasting insulin with HOMA-IR, HbA1c, uric acid, homocysteine, and liver and kidney markers. Together these describe the process that leads to cardiovascular and metabolic disease years before a conventional threshold is crossed.

How it works, step by step

  1. Consultation: personal and family history, blood pressure, body composition, medications and current risk.
  2. Panel selection: markers chosen to answer a specific question about your risk, not a fixed bundle.
  3. Fasting draw: done at the clinic or at a laboratory near you.
  4. Risk interpretation: results combined with your history into a picture of trajectory, not a snapshot.
  5. Plan and retest: nutrition, training, sleep, and medication where indicated, with a defined date to measure whether it worked.

Who it’s for, and who it isn’t

Likely a good fit: adults with a family history of early heart disease or type 2 diabetes, anyone with borderline glucose, lipids or blood pressure, patients whose weight or waist has changed despite consistent effort, and high performers who want risk measured properly rather than assumed away.

Likely not a fit: anyone with current chest pain, breathlessness on exertion or other acute cardiac symptoms. That calls for an urgent cardiology evaluation, not an advanced panel. If you are having chest pain now, call 911.

What to expect at your first visit

The first appointment is a risk consultation. We review your history, measure blood pressure and body composition, and decide which markers would change your plan. After the draw, results are reviewed with you in a dedicated appointment where we set explicit targets and a timeline for re-measuring them.

What the numbers can and cannot tell you

Advanced markers describe risk more precisely; they do not visualize your arteries. Where the picture warrants it, we will recommend imaging such as a coronary artery calcium score and coordinate with a cardiologist rather than treating a number in isolation.

We also avoid over-treating. Some markers are strongly tied to outcomes and worth acting on; others are informative but not yet a target in their own right. We will tell you which category each of your results falls into.

Pricing and insurance

Organic Well does not participate with insurance plans. Panel and consultation costs are disclosed before anything is ordered, and superbills are provided for potential out-of-network reimbursement.

Cardiometabolic testing in Coconut Grove, Miami

Testing and review appointments take place at 3661 S. Miami Ave, Suite 1003, serving Brickell, Coral Gables, South Miami and Key Biscayne, with lab draws arranged locally and reviews by secure video for patients elsewhere in Florida.

Further reading

Evidence

What the research says

Peer-reviewed sources, quoted directly, including where the evidence is thin.

  • apoB is a more accurate marker of cardiovascular risk than either LDL-C or non-HDL-C, notwithstanding these variables are highly intercorrelated.

    Sniderman AD. ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease. Clinical Chemistry, 2021.

    Discordance analysis, which studies the people in whom these correlated measures disagree, is what separates them. When they diverge, risk follows apoB.

  • All major lipid guidelines recognize that both non-HDL-C and apoB are more accurate measures of cardiovascular risk than LDL-C.

    Sniderman AD et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 2019.

    Which is why a standard cholesterol panel is a starting point rather than a conclusion, particularly in patients with high triglycerides, obesity or diabetes.

  • The coronary calcium score is a strong predictor of incident coronary heart disease and provides predictive information beyond that provided by standard risk factors in four major racial and ethnic groups in the United States.

    Detrano R et al. Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups. New England Journal of Medicine, 2008 (MESA).

    6,722 adults with no clinical cardiovascular disease at entry. Compared with a calcium score of zero, the adjusted risk of a coronary event was 7.73 times higher with a score of 101 to 300 and 9.67 times higher above 300, and the predictive value held across white, Black, Hispanic and Chinese participants.

Our position

We order ApoB because it answers the question a cholesterol panel only approximates, and lipoprotein(a) because it is inherited, measured once, and changes how aggressively everything else should be managed. We set explicit targets from those numbers and re-measure them. What we do not do is treat a marker that has no outcome data behind it simply because it is available.

Frequently asked questions

In-clinic in Coconut Grove and via telehealth across Florida · (305) 930-8891

Cardiometabolic testing evaluates metabolism, cardiovascular markers, inflammation, and blood sugar regulation.

Advanced testing evaluates patterns such as insulin resistance, lipid particles, and inflammation markers.

Not necessarily. Many patients use cardiometabolic testing for prevention and health optimization.

Timing depends on the laboratory and type of testing.

Yes. Results are reviewed with a medical professional and integrated into a care plan.

Yes. Functional medicine often uses advanced lab testing to guide metabolic health care.

Particle-level lipoproteins (like ApoB), inflammatory markers, insulin resistance indices, and related metabolic signals.

Adults with family history, borderline results, or anyone building a serious prevention plan.

A physician review visit translating results into nutrition, training and, when appropriate, medical therapy.

Contact

Request a consultation

Share a few details and our team will reach out within one business day.

Visit us

3661 S. Miami Ave, Suite 1003Miami, FL 33133 · United States By appointment · Mon–Fri, 9 AM – 6 PM

Your contact details

I'm interested in

Tell us about your goals

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.